Compare Costco Wholesale Corporation (COST) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Costco Wholesale Corporation vs Illumina, Inc. — how do they compare? Costco Wholesale Corporation trades at $921 (market cap $408.78B), while Illumina, Inc. trades at $186.87 (market cap $28.93B). The key difference: Costco Wholesale Corporation is far larger — about 14.1× Illumina, Inc.'s market cap, and Costco Wholesale Corporation pays a 0.64% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| COST | ILMN | |
|---|---|---|
Market Cap | $408.78B | $28.93B |
Sector | Consumer Staples | Health |
52-Week High | $1.09K | $194.33 |
52-Week Low | $849.63 | $91.00 |
Enterprise Value | $396.92B | $30.32B |
Dividend Yield | 0.64% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Costco (COST) trades at $921.73, down 0.51% on the day, with a bearish technical signal but strong fundamental growth. Revenue reached $275.24B in 2025 with net income of $8.10B, and March 2026 sales grew 11.3% year-over-year. The stock carries premium valuations (P/E 46.37, P/S 1.4) while maintaining steady margin expansion. Analyst consensus remains strongly bullish with a $1,120 price target, though recent earnings miss in Q1 2026 highlights execution risks amid high expectations.
Outlook: Costco's membership fee increase and warehouse expansion support long-term growth, but elevated valuation requires flawless execution. Risks include competitive pressures and macroeconomic sensitivity. Institutional accumulation continues, with 65% analyst buy ratings signaling confidence in the company's resilient business model and cash flow generation.
Illumina (ILMN) trades at $190.05, showing strong momentum with a 43.7% gain year-to-date and recent earnings beats. The stock is technically bullish, trading near resistance at $191 with solid fundamentals including 19.42% net margins and robust cash flow. Recent leadership appointments and product launches like StrataMap Spatial Solution highlight ongoing innovation in genomics sequencing.
Outlook remains positive driven by sequencing demand and margin expansion, but risks include competitive pressure from Roche's new sequencer and China market weakness. Analyst consensus is bullish with 51% buy ratings, though the current price exceeds the $174.44 target, suggesting near-term valuation concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Costco Wholesale Corporation
The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet
Read more on COST →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
